Found 103 matching trials
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
PHASE3This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Location
Liuzhou center for disease control and prevention
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
PHASE4The goal of this clinical trial is to compare a 2-dose and 3-dose series of...
Location
University of Texas Medical Branch
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
PHASE4This phase IV trial studies how well human papillomavirus (HPV) vaccine the...
Location
University of Alabama at Birmingham Cancer Center
Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)
PHASE3The primary objective of this study is the estimation of the human papillom...
Location
Sotobo Children's Clinic ( Site 6616)
HPV Vaccine in Postpartum Women
N/AThe purpose of this study is to determine the acceptability of HPV vaccinat...
Location
Multiple Locations
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
PHASE3This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial
PHASE3A randomized, observer-blind non-inferiority trial to evaluate alternative ...
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
PHASE1The main purpose of this study was to evaluate the safety and reactogenicit...
Location
GSK Investigational Site
Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)
PHASE3This is an immunogenicity and safety study of Gardasil (V501) in females 9 ...
Location
Multiple Locations
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia
PHASE2Background:
Diseases related to human papillomavirus (HPV) include warts, ...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center